Evidence map›Paper›PMID 36402774›Full record

ArticleScientific reports2022

Experimental and theoretical studies of linear and non-linear optical properties of novel fused-triazine derivatives for advanced technological applications.

Hamdan A S Al-Shamiri, Mahmoud E M Sakr, Samir A Abdel-Latif, Nabel A Negm, Maram T H Abou Kana, Samy A El-Daly, Ahmed H M Elwahy

Abstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Isoxazolyl-Derived 1,4-Dihydroazolo[5,1-Molecules (Basel, Switzerland) · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Hamdan A S Al-ShamiriPhysics Department, Faculty of Science, University of Bisha, P.O. Box 551, Bisha, 61922, Saudi Arabia.
Mahmoud E M SakrLaser Sciences and Interactions Department, National Institute of Laser-Enhanced Sciences (NILES), Cairo University, Giza, Egypt.
Samir A Abdel-LatifDepartment of Chemistry, Faculty of Science, Helwan University, Cairo, 11795, Egypt.
Nabel A NegmEgyptian Petroleum Research Institute (EPRI), Nasr City, 11727, Cairo, Egypt.
Maram T H Abou KanaLaser Sciences and Interactions Department, National Institute of Laser-Enhanced Sciences (NILES), Cairo University, Giza, Egypt. mabou202@niles.edu.eg.
Samy A El-DalyChemistry Department, Faculty of Science, Tanta University, Tanta, Egypt.
Ahmed H M ElwahyChemistry Department, Faculty of Science, Cairo University, Giza, Egypt. aelwahy@cu.edu.eg.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Controlling photophysical properties is critical for the continued development of electroluminescent devices and luminescent materials. The preparation and study of novel molecules suitable as luminescent for the development of optoelectrical devices have recently received a lot of attention. Even though the as-triazine unit is a good building block for organic active substances, it is rarely used in this context. We created here novel bis-triazine derivative dyes in the far UV-Vis range by alkylation of triazine-thione derivatives with appropriate dibromo compounds. At the B3LYP/6-311**G(d,p) basis set, their optimal molecular structures were obtained. DFT technique confirmed that the new triazine derivatives are in noncoplanar with one of the two phenyl rings and the triazine plane rotating out by 102.09. Also, depending on the energy gap difference between HOMO and LUMO, some important parameters including chemical potential (π), electronegativity (χ), and chemical hardness (η) were calculated. The compounds may be readily polarized and have significant NLO characteristics, as seen by the tiny HOMO-LUMO energy gap. The calculated values for the polarizability (α) of the two new triazine derivatives have the range 6.09-10.75 × 10

Identifiers

PMID36402774
PMCPMC9675782

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.